Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makio Shozu

Showing results (101-110 of 193) with videos related to

Pageof 20
Sort By:
BMC Cancer|June 23, 2007
Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case reportGiacomo Puppa, Makio Shozu, Tiziana Perin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissuesHui-Juan Yang, Makio Shozu, Kouichi Murakami, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19)Makio Shozu, Hiroshi Sumitani, Tomoya Segawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2016
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studyShinsuke Hanawa, Akira Mitsuhashi, Ayumu Matsuoka, et al.
Cancers|July 2, 2021
Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell CarcinomaShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
American Journal of Obstetrics and Gynecology|November 6, 2007
Serum p53 antibody as a diagnostic marker of high-risk endometrial cancerKoji Yamazawa, Hideaki Shimada, Makiko Hirai, et al.
Public Health in Practice (Oxford, England)|July 18, 2022
Long-term observation of antibody titers against SARS-CoV-2 following vaccinationKazuo Sugiyama, Chouji Suzuki, Masanori Aoyama, et al.
Acta Cytologica|March 24, 2010
Cytologic findings of low grade endometrial stromal sarcoma with sex cord-like differentiation: a case reportKyoko Nishikimi, Nobuya Habuka, Yuko Okazima, et al.
The Journal of Obstetrics and Gynaecology Research|June 23, 2015
Management of secondary infertility following cesarean section: Report from the Subcommittee of the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and GynecologyShunichiro Tsuji, Takashi Murakami, Fuminori Kimura, et al.
The Journal of Reproductive Medicine|July 19, 2016
Comparison Between Pathological Diagnosis and Cytogenetic Diagnosis by Short Tandem Repeat Polymorphism Analysis of Suspected Molar PregnanciesHirokazu Usui, Takako Kiyokawa, Jia Qu, et al.
Pageof 20

Showing results (101-110 of 193) with videos related to

Sort By:
Pageof 20
BMC Cancer|June 23, 2007
Small primary adenocarcinoma in adenomyosis with nodal metastasis: a case reportGiacomo Puppa, Makio Shozu, Tiziana Perin, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2002
Spatially heterogeneous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic factor-1 transcript in endometrioma tissuesHui-Juan Yang, Makio Shozu, Kouichi Murakami, et al.
The Journal of Clinical Endocrinology and Metabolism|June 7, 2002
Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19)Makio Shozu, Hiroshi Sumitani, Tomoya Segawa, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 12, 2016
Efficacy of palonosetron plus aprepitant in preventing chemoradiotherapy-induced nausea and emesis in patients receiving daily low-dose cisplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a phase II studyShinsuke Hanawa, Akira Mitsuhashi, Ayumu Matsuoka, et al.
Cancers|July 2, 2021
Bevacizumab in First-Line Chemotherapy Improves Progression-Free Survival for Advanced Ovarian Clear Cell CarcinomaShinichi Tate, Kyoko Nishikimi, Ayumu Matsuoka, et al.
American Journal of Obstetrics and Gynecology|November 6, 2007
Serum p53 antibody as a diagnostic marker of high-risk endometrial cancerKoji Yamazawa, Hideaki Shimada, Makiko Hirai, et al.
Public Health in Practice (Oxford, England)|July 18, 2022
Long-term observation of antibody titers against SARS-CoV-2 following vaccinationKazuo Sugiyama, Chouji Suzuki, Masanori Aoyama, et al.
Acta Cytologica|March 24, 2010
Cytologic findings of low grade endometrial stromal sarcoma with sex cord-like differentiation: a case reportKyoko Nishikimi, Nobuya Habuka, Yuko Okazima, et al.
The Journal of Obstetrics and Gynaecology Research|June 23, 2015
Management of secondary infertility following cesarean section: Report from the Subcommittee of the Reproductive Endocrinology Committee of the Japan Society of Obstetrics and GynecologyShunichiro Tsuji, Takashi Murakami, Fuminori Kimura, et al.
The Journal of Reproductive Medicine|July 19, 2016
Comparison Between Pathological Diagnosis and Cytogenetic Diagnosis by Short Tandem Repeat Polymorphism Analysis of Suspected Molar PregnanciesHirokazu Usui, Takako Kiyokawa, Jia Qu, et al.
Pageof 20